Discover 1,398 paid clinical trials in Sarasota, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,398
Active & ResponsiveNew
Effects of Recursive Self-feedback on Speech Production in Aphasia
for
Aphasia, Stroke
Location: Tampa FL
Sponsor: University of South Florida
Sex: All
Age: 18 - 70+
Code: NCT06323629
Recruiting
Active & Responsive
BBD Longitudinal Study of Osteogenesis Imperfecta
for
Osteogenesis Imperfecta
Location: Tampa FL, Houston TX, Washington D.C. DC, Baltimore MD,
Sponsor: Baylor College of Medicine
Sex: All
Age: 0+
Code: NCT02432625
Recruiting
Active & Responsive
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
for
Type 1 Diabetes Mellitus
Location: Tampa FL, Gainesville FL, Miami FL, Nashville TN,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 8 - 45
Code: NCT07142252
Phase2, Recruiting
Active & Responsive
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
for
Diabetic Retinopathy, Macular Edema
Location: Tampa FL, Bluffton SC, West Columbia SC, Florence SC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07705555
Phase3, Recruiting
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
for
Treatment Resistant Depression
Location: Tampa FL, Hollywood FL, Miami FL, Savannah GA,
Sponsor: atai Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06524830
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for
Parkinson Disease
Location: Tampa FL, Orlando FL, Boca Raton FL, Hallandale FL,
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All
Age: 30 - 70+
Code: NCT07432958
Phase2, Recruiting
Active & Responsive
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer